115 Results

People

  1. Livingston
    Livingston
  2. Ragupathi
    Ragupathi
  3. Oettgen
    Oettgen
  4. Adluri
    Adluri
  5. Lloyd
    Lloyd
  6. Danishefsky
    Danishefsky
  7. Jones Calves
    Jones Calves
  8. Old
    Old
  9. Chapman
    Chapman
  10. Helling
    Helling

Groups

  1. Department of Medicine (52)
  2. Melanoma Disease Management Team (36)
  3. Solid Tumor Oncology Division (35)
  4. Melanoma and Immunotherapeutics Service (31)
  5. Sloan Kettering Institute Faculty (26)
  6. Hematologic Malignancies, Division of (22)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (18)
  8. Center for Hematologic Malignancies (15)
  9. Molecular Pharmacology and Chemistry Program Faculty (15)
  10. GSK Faculty (14)
  1. "immunoglobulin m"
Formats
  1. Journal Article (111)
  2. Conference Paper (2)
  3. Editorial (1)
  4. Review (1)
Groups
  1. Department of Medicine (52)
  2. Melanoma Disease Management Team (36)
  3. Solid Tumor Oncology Division (35)
  4. Melanoma and Immunotherapeutics Service (31)
  5. Sloan Kettering Institute Faculty (26)
  6. Hematologic Malignancies, Division of (22)

More Groups

People
  1. Philip Livingston (43)
  2. Govindaswami Ragupathi (22)
  3. Herbert Oettgen (11)
  4. Sucharita Adluri (10)
  5. Kenneth Lloyd (9)
  6. Lloyd Old (8)

More People

Years
  1. 2025 (3)
  2. 2024 (3)
  3. 2023 (1)
  4. 2022 (1)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publications
  1. Cancer Immunology, Immunotherapy (11)
  2. Clinical Cancer Research (9)
  3. International Journal of Cancer (6)
  4. Cancer Research (5)
  5. Proceedings of the National Academy of Sciences of the United States of America (5)
  6. Blood (4)

More Publications

Publishers
  1. American Association for Cancer Research (14)
  2. Elsevier Inc. (14)
  3. Springer (14)
  4. John Wiley & Sons (9)
  5. National Academy of Sciences (5)
  6. American Society of Hematology (4)

More Publishers

Results (115)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Persistent hypogammaglobulinemia after rituximab therapy in pediatric patients, prevalence and clinical outcomes: Hypogammaglobulinemia after rituximab in children
    Journal Article

    Höppener, S. P. C.; Veldkamp, S. R.; de Groot, M. C. H.; Haitjema, S.; Drylewicz, J.; Boelens, J. J.; Lindemans, C. A.; van Montfrans, J.; van Royen-Kerkhof, A.; Jansen, M. H. A.
    Clinical Immunology Communications (2025)

    Fulltext@MSK | Save
  • Monoclonal gammopathy of undetermined significance and the risk of thrombotic events: Results from iStopMM, a prospective population-based screening study
    Journal Article

    Rögnvaldsson, S.; Gasparini, A.; Thorsteinsdottir, S.; Sverrisdottir, I.; Eythorsson, E.; Long, T. E.; Palmason, R.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B. A.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Evaluating serum free light chain ratio as a biomarker in multiple myeloma
    Journal Article

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Lu, S. X.; Patel, D.; Shah, U. A.; Tan, C. R.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population-based screening study
    Journal Article

    Rögnvaldsson, S.; Óskarsson, J. Þ.; Thorsteinsdóttir, S.; Hultcrantz, M.; Palmason, R.; Sverrisdottir, I. S.; Eythorsson, E.; Long, T. E.; Olafsson, I.; Thorsteinsdottir, I.; more...
    HemaSphere (2024)

    Fulltext@MSK | Save
  • Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001
    Journal Article

    Abramson, J. S.; Palomba, M. L.; Gordon, L. I.; Lunning, M.; Wang, M.; Arnason, J.; Purev, E.; Maloney, D. G.; Andreadis, C.; Sehgal, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Dynamic encounters with red blood cells trigger splenic marginal zone B cell retention and function
    Journal Article

    Liu, D.; Winer, B. Y.; Chou, M. Y.; Tam, H.; Xu, Y.; An, J.; Gardner, J. M.; Cyster, J. G.
    Nature Immunology (2024)

    Fulltext@MSK | Save
  • Plasma cell neoplasms and related entities—Evolution in diagnosis and classification
    Review

    Fend, F.; Dogan, A.; Cook, J. R.
    Virchows Archiv (2023)

    Fulltext@MSK | Save
  • Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition
    Journal Article

    Ghosh, N.; Postow, M.; Zhu, C.; Jannat-Khah, D.; Li, Q. Z.; Vitone, G.; Chan, K. K.; Bass, A. R.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of diagnostic testing for SARS–CoV-2/COVID-19
    Editorial

    Patel, R.; Babady, E.; Theel, E. S.; Storch, G. A.; Pinsky, B. A.; St. George, K.; Smith, T. C.; Bertuzzi, S.
    mBio (2020)

    Fulltext@MSK | Save
  • Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: The phase II GATHER study
    Journal Article

    Sharman, J. P.; Forero-Torres, A.; Costa, L. J.; Flinn, I. W.; Inhorn, L.; Kelly, K.; Bessudo, A.; Fayad, L. E.; Kaminski, M. S.; Evens, A. M.; more...
    Leukemia and Lymphoma (2019)

    Fulltext@MSK | Save